Lyn M. Dyster
Private Equity Investor chez Volante Capital LLC
Profil
Dr. Lyn M.
Dyster is a Managing Director at Volante Capital LLC.
Dr. Dyster was previously employed as a Senior Vice President-Operations by Athenex, Inc. and a Principal by Cellular Products, Inc.
She received her undergraduate degree from Washington & Jefferson College, a doctorate degree from State University of New York at Buffalo and a doctorate degree from State University of New York at Buffalo.
Postes actifs de Lyn M. Dyster
| Sociétés | Poste | Début |
|---|---|---|
Volante Capital LLC
 Volante Capital LLC Investment ManagersFinance Volante Capital LLC (Volante Capital) is a private equity firm founded in 2006 by Victor Lazzaro and Terry W. White. The firm is headquartered in Denver, Colorado. | Private Equity Investor | - |
Anciens postes connus de Lyn M. Dyster
| Sociétés | Poste | Fin |
|---|---|---|
Cellular Products, Inc.
 Cellular Products, Inc. Medical SpecialtiesHealth Technology Cellular Products, Inc. manufactures biotechnology materials for diagnostic test kits. The private company is based in Buffalo, NY. The company was founded by Jeffrey N. Meshulam. | Corporate Officer/Principal | - |
| ATHENEXPAR | Fondateur | - |
Formation de Lyn M. Dyster
| State University of New York at Buffalo | Doctorate Degree |
| Washington & Jefferson College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Cellular Products, Inc.
Cellular Products, Inc. Medical SpecialtiesHealth Technology Cellular Products, Inc. manufactures biotechnology materials for diagnostic test kits. The private company is based in Buffalo, NY. The company was founded by Jeffrey N. Meshulam. | Health Technology |
Athenex, Inc.
 Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
Volante Capital LLC
Volante Capital LLC Investment ManagersFinance Volante Capital LLC (Volante Capital) is a private equity firm founded in 2006 by Victor Lazzaro and Terry W. White. The firm is headquartered in Denver, Colorado. | Finance |
